MenoQUICK

Description

A new stage in life?

MenoQUICK is a qualitative test for home use to detect the status of menopause with 99,9% accuracy.
The test measures the concentration of the Follicle Stimulating Hormone (FSH) in the urine and indicates whether or not a woman has entered into menopause. This knowledge provides the possibility to discuss hormone treatment with a gynaecologist or doctor to evaluate the risk of osteoporosis.

Background

The typical “mature woman” is aged 40 years or older and has completed childbearing. During their late 40’s, most women enter the menopausal transition. This period of physiological change is due to ovarian senescence (the process of deterioration with age) and estrogen decline and is usually completed between ages 51 and 56. Menopause marks a defining point in this transition. Specifically, menopause is defined by the World Health Organization as the point in time of permanent menstruation cessation due to loss of ovarian function. Clinically, the menopause refers to a point in time that follows 1 year after menstruation cessation. The time leading up to menopause is called perimenopause. With ovarian senescence, declining hormone levels have specific effects on many tissues. Some effects lead to physical complaints, such as vasomotor symptoms (night sweats, hot flashes, and flushes) and vaginal dryness, whereas others are metabolic and structural changes. These include osteopenia, osteoporosis, skin thinning, fatty replacement of the breast, cardiovascular changes, and genitourinary atrophy. As a result, postmenopausal women have specific issues associated with ageing and estrogen loss that may negatively affect their individual health (Hoffman et. al., 2012).

http://accessmedicine.mhmedical.com/content.aspx?sectionid=41722311&bookid=399&jumpsectionID=41727768&Resultclick=2

MenoQUICK detects the level of FSH to prove whether or not a woman has entered perimenopause (the time when the ovaries gradually begin to make less estrogen). If a woman knows that she has already entered perimenopause, she has the possibility to take the necessary steps to keep her body healthy and to avoid risks involved in menopause (e.g. osteoporosis, rising blood pressure, high cholesterol).

Advantage of self-test:

• Safe & easy test procedure at home with immediate results.
• Narrows down the possible cause of symptoms. A doctor or gynaecologist can use these results to discuss hormone treatment to evaluate the risk of osteoporosis.

Who should get tested?

Mature women (around age 40) showing signs of menopause:

• irregular menstruation, which finally stops completely
• hot flashes
• hair loss
• sleep disorders
• vaginal dryness

Additional Info:

• To perform the test, please use first-morning urine that contains the highest concentration of hormones and gives you the most accurate results.
• If you still get your period, the first test should be performed during the first week of the menstrual cycle (day 2-7, with day 1 as the first day of menstruation). One week later the FSH level should be determined again using the second test device.
• If you do not have a regular menstrual cycle, perform the first test at any time of the month and the second test one week later.
• Oral contraceptives, hormone replacement therapy or estrogen supplements may affect FSH levels and cause false negative results.
• Ovarian or pituitary tumours may cause false negative results.
• This test must not be used to determine fertility. Contraception decisions should not be made based on test results.